SEC Form 4 · accession 0001209191-19-002552
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Alison Cecily Finger
Officer — Chief Commercial Officer
Period of report
Jan 3, 2019
Accepted (ET)
Jan 7, 2019 · 4:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Jan 3, 2019 | S | 108 | $98.3142 | D | 15,559 | D | |
| Common StockF1,F3 | Jan 3, 2019 | S | 205 | $99.2734 | D | 15,354 | D | |
| Common StockF1 | Jan 3, 2019 | S | 115 | $100.32 | D | 15,239 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units.
- F2The range in prices for the transaction reported on this line was $98.07 to $98.845. The average weighted price was $98.3142. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F3The range in prices for the transaction reported on this line was $99.08 to $99.805. The average weighted price was $99.2734. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.